STOCK TITAN

Liquidia Corp (LQDA) CMO cashes in options, unloads 79K+ shares

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Liquidia Corp (LQDA) reported that its Chief Medical Officer, Rajeev Saggar, exercised a non-qualified stock option for 50,000 shares of common stock at an exercise price of $3.73 per share. On the same date, he sold 50,000 shares of common stock at a volume weighted average price of $74.06, and two days earlier sold an additional 29,534 shares at a volume weighted average price of $76.84. Following the option exercise, he continued to hold 150,000 stock options; separate footnote disclosure indicates additional holdings of unvested RSUs and shares acquired under the employee stock purchase plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Saggar Rajeev
Role Chief Medical Officer
Sold 79,534 shs ($5.97M)
Approx. gross sale proceeds $5.97M
Approx. exercise cost $187K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) F5 50,000 $0.00 $0.00
Exercise Common Stock F2 50,000 $3.73 $187K
Sale Common Stock F3, F4, F2 50,000 $74.0565 $3.70M
Sale Common Stock F1, F2 29,534 $76.8396 $2.27M
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 150,000 shares (Direct); Common Stock — 142,265 shares (Direct)
Footnotes (5)
  1. F1. Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $76.76 to $77.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
  3. F3. Represents the subsequent sale of the underlying shares from the exercise of stock options reported on this Form 4.
  4. F4. Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $74.00 to $74.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The option vested over a four-year period with 25% vesting on July 18, 2023 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on July 18, 2026.
Options Exercised 50,000 shares Non-qualified stock option for common stock exercised at $3.73 per share
Exercise Price $3.73 per share Conversion or exercise price of the non-qualified stock option
Sale on 2026-08-17 29,534 shares at $76.8396 per share Common stock sale using a volume weighted average price range $76.76–$77.13
Sale on 2026-08-19 50,000 shares at $74.0565 per share Common stock sale using a volume weighted average price range $74.00–$74.60
Total Shares Sold 79,534 shares Aggregate common shares sold across reported transactions
Options Held After Exercise 150,000 options Total shares underlying options reported as held following the option transaction
ESPP Shares Held 2,650 shares Shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
restricted stock units ("RSUs") financial
"Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
volume weighted average price financial
"Price is the volume weighted average price of all transactions made"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
Employee Stock Purchase Plan financial
"shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

What did Liquidia Corp (LQDA) insider Rajeev Saggar do in this Form 4?

Rajeev Saggar exercised 50,000 stock options at $3.73 and sold a total of 79,534 common shares at volume weighted average prices in the mid-$70s, while retaining a substantial option and equity position.

How many Liquidia Corp (LQDA) options did Rajeev Saggar exercise and at what price?

He exercised a non-qualified stock option for 50,000 shares of Liquidia common stock at an exercise price of $3.73 per share, converting the derivative position into common shares that were then partly sold.

At what prices did Rajeev Saggar sell LQDA common stock in this filing?

He sold 29,534 shares at a volume weighted average price of $76.8396 and 50,000 shares at a volume weighted average price of $74.0565, with detailed per-trade prices available on request from the company or the SEC staff.

How many Liquidia Corp (LQDA) shares did Rajeev Saggar sell in total?

Across the reported transactions, he sold 79,534 shares of Liquidia common stock, combining a 29,534-share sale on one date with a 50,000-share sale that followed the exercise of stock options reported in this Form 4.

What Liquidia Corp (LQDA) equity does Rajeev Saggar continue to hold after these transactions?

After exercising options, he held 150,000 non-qualified stock options. A footnote also states that his remaining equity includes specified blocks of unvested RSUs from grants in 2023–2026 and 2,650 shares from the 2020 Employee Stock Purchase Plan.

Were Rajeev Saggar’s LQDA trades made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan, and the footnotes do not state that these transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Saggar Rajeev

(Last)(First)(Middle)
419 DAVIS DRIVE
SUITE 100

(Street)
MORRISVILLE NORTH CAROLINA 27560

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Liquidia Corp [ LQDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026S29,534D$76.8396(1)142,265(2)D
Common Stock08/19/2026M50,000A$3.73192,265(2)D
Common Stock08/19/2026S(3)50,000D$74.0565(4)142,265(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$3.7308/19/2026M50,00007/18/2026(5)07/18/2032Common Stock50,000$0150,000D
Explanation of Responses:
1. Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $76.76 to $77.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
3. Represents the subsequent sale of the underlying shares from the exercise of stock options reported on this Form 4.
4. Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $74.00 to $74.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The option vested over a four-year period with 25% vesting on July 18, 2023 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on July 18, 2026.
/s/ Dr. Rajeev Saggar08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)